small sample sizes hamper companies ability exacting correlations genetic variations health disease risk company boyce involved gnubio aims drop cost sequencing $ 30 genome years fast cheap sequencing expects number logged genomes skyrocket numbers genomes high boyce says power deeper genome find predictive biomarkers companies offering personal genome scans use algorithms calculating person disease risk health information validity results remained relatively unexamined pathway genomics consumer test controversy spring fda sent companies requesting meetings discuss regulatory future genetic products firms--23andme decode knome navigenics offer direct consumer genome scans personal genome service complete scan knomecompete health compass respectively fda labeled medical devices